

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.47066051 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.28928127 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.28928127 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.28928127 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.28928127 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.28928127 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.28928127 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 5.09990818 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02355245 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.99777438 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.99777438 |
| 12 | response to peptidoglycan (GO:0032494) | 4.86150980 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.76192641 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.72272571 |
| 15 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.64580052 |
| 16 | cellular extravasation (GO:0045123) | 4.62931683 |
| 17 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.60534945 |
| 18 | detection of other organism (GO:0098543) | 4.43322986 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.34424571 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.29102890 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.17056115 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.08461732 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.05120971 |
| 24 | detection of bacterium (GO:0016045) | 3.97773493 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.87322530 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86602552 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.85269365 |
| 28 | leukocyte aggregation (GO:0070486) | 3.84341419 |
| 29 | cellular response to ATP (GO:0071318) | 3.79192881 |
| 30 | respiratory burst (GO:0045730) | 3.77755761 |
| 31 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.77117904 |
| 32 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.74058405 |
| 33 | detection of biotic stimulus (GO:0009595) | 3.68125901 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.67620936 |
| 35 | neutrophil activation (GO:0042119) | 3.66624459 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62070208 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 3.61563550 |
| 38 | response to interleukin-15 (GO:0070672) | 3.59986374 |
| 39 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.58031904 |
| 40 | adenosine receptor signaling pathway (GO:0001973) | 3.57541927 |
| 41 | neutrophil mediated immunity (GO:0002446) | 3.57345827 |
| 42 | macrophage activation (GO:0042116) | 3.55042555 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 3.51974512 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50381345 |
| 45 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.49856642 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.49793996 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.49378998 |
| 48 | germinal center formation (GO:0002467) | 3.48309139 |
| 49 | granulocyte activation (GO:0036230) | 3.45147910 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44586174 |
| 51 | response to host immune response (GO:0052572) | 3.44586174 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43561021 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.41515285 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.40141695 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38384899 |
| 56 | regulation of interferon-alpha production (GO:0032647) | 3.30845549 |
| 57 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.27622953 |
| 58 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.27399722 |
| 59 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.25863570 |
| 60 | negative regulation of interleukin-8 production (GO:0032717) | 3.21448641 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.21291239 |
| 62 | microglial cell activation (GO:0001774) | 3.20609475 |
| 63 | leukocyte degranulation (GO:0043299) | 3.18706261 |
| 64 | response to host (GO:0075136) | 3.16200797 |
| 65 | response to host defenses (GO:0052200) | 3.16200797 |
| 66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16200797 |
| 67 | interferon-gamma production (GO:0032609) | 3.14060896 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11509500 |
| 69 | B cell receptor signaling pathway (GO:0050853) | 3.11143153 |
| 70 | regulation of toll-like receptor signaling pathway (GO:0034121) | 3.08211415 |
| 71 | negative regulation of innate immune response (GO:0045824) | 3.07296167 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 3.06601986 |
| 73 | GDP-mannose metabolic process (GO:0019673) | 3.05129480 |
| 74 | negative regulation of cell aging (GO:0090344) | 3.04318531 |
| 75 | purinergic receptor signaling pathway (GO:0035587) | 3.04211163 |
| 76 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.02054701 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01718400 |
| 78 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.01089230 |
| 79 | myeloid leukocyte mediated immunity (GO:0002444) | 2.98146513 |
| 80 | regulation of interferon-beta production (GO:0032648) | 2.96311969 |
| 81 | positive regulation of interferon-beta production (GO:0032728) | 2.94204789 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.93330468 |
| 83 | response to type I interferon (GO:0034340) | 2.92734044 |
| 84 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.91801004 |
| 85 | response to ATP (GO:0033198) | 2.90778527 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89453949 |
| 87 | cellular response to type I interferon (GO:0071357) | 2.88701917 |
| 88 | type I interferon signaling pathway (GO:0060337) | 2.88701917 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.87526031 |
| 90 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.87526031 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 2.83263449 |
| 92 | regulation of leukocyte degranulation (GO:0043300) | 2.82956020 |
| 93 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.82054930 |
| 94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81522921 |
| 95 | defense response to protozoan (GO:0042832) | 2.79722216 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79703052 |
| 97 | mannose metabolic process (GO:0006013) | 2.79506735 |
| 98 | tolerance induction (GO:0002507) | 2.77086421 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.76836133 |
| 100 | regulation of mast cell activation (GO:0033003) | 2.73815003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.16019535 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.52239221 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.31438198 |
| 4 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.90470332 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86357820 |
| 6 | MAF_26560356_Chip-Seq_TH1_Human | 2.80854828 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72555407 |
| 8 | MAF_26560356_Chip-Seq_TH2_Human | 2.70646943 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49503481 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.48950873 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.48218739 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41174072 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.37084906 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35971632 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.35379436 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.24262503 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 2.23044019 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.17337870 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.16212201 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12147510 |
| 21 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.04819521 |
| 22 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.04364452 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98938383 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.96099481 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.92059852 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87463892 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81201333 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80097740 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79087423 |
| 30 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.78576331 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77844122 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75089983 |
| 33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.72515200 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69817348 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68086591 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64822066 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61872559 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61352119 |
| 39 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.59359584 |
| 40 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.58366123 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.57998704 |
| 42 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.56443915 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55811164 |
| 44 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.54375859 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.50983823 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.50207756 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.49319499 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49232417 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48354391 |
| 50 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.48209621 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47199266 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46547365 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46430586 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.46313440 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45614945 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44481708 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41280315 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41011973 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40025297 |
| 60 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.39746984 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 1.34547418 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34526565 |
| 63 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.34074834 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33115502 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32984643 |
| 66 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.32736149 |
| 67 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.31131506 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28504743 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27830792 |
| 70 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27715626 |
| 71 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25637678 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24668312 |
| 73 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23347323 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23304509 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22330122 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20713037 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20239783 |
| 78 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19293590 |
| 79 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16767944 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15900038 |
| 81 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15621809 |
| 82 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.15580579 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15576427 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15403915 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15360294 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14294266 |
| 87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13830449 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13613668 |
| 89 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12793827 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12670491 |
| 91 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.11817760 |
| 92 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11496551 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11448200 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11363403 |
| 95 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10172168 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 1.09482917 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08711329 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08110397 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08054801 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07864817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 5.60854292 |
| 2 | MP0001986_abnormal_taste_sensitivity | 4.49127270 |
| 3 | MP0003724_increased_susceptibility_to | 4.18031572 |
| 4 | MP0003303_peritoneal_inflammation | 3.87503407 |
| 5 | MP0005174_abnormal_tail_pigmentation | 3.53663286 |
| 6 | MP0003436_decreased_susceptibility_to | 3.36207937 |
| 7 | MP0004381_abnormal_hair_follicle | 3.07603183 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.44247134 |
| 9 | MP0005171_absent_coat_pigmentation | 2.41849040 |
| 10 | MP0002419_abnormal_innate_immunity | 2.30686657 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.27488392 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.19606792 |
| 13 | MP0005025_abnormal_response_to | 2.16848025 |
| 14 | MP0001800_abnormal_humoral_immune | 2.12905831 |
| 15 | MP0002723_abnormal_immune_serum | 2.01018001 |
| 16 | MP0005409_darkened_coat_color | 1.98457025 |
| 17 | MP0000015_abnormal_ear_pigmentation | 1.93474762 |
| 18 | MP0005000_abnormal_immune_tolerance | 1.91704162 |
| 19 | MP0002132_abnormal_respiratory_system | 1.88778657 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.88383052 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.88368616 |
| 22 | MP0001790_abnormal_immune_system | 1.88216513 |
| 23 | MP0005387_immune_system_phenotype | 1.88216513 |
| 24 | MP0001819_abnormal_immune_cell | 1.86858390 |
| 25 | MP0000685_abnormal_immune_system | 1.86013563 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.79632427 |
| 27 | MP0009278_abnormal_bone_marrow | 1.77873791 |
| 28 | MP0005671_abnormal_response_to | 1.76902326 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 1.73046706 |
| 30 | MP0009785_altered_susceptibility_to | 1.69086286 |
| 31 | MP0003136_yellow_coat_color | 1.63685291 |
| 32 | MP0006082_CNS_inflammation | 1.62133217 |
| 33 | MP0003878_abnormal_ear_physiology | 1.60359753 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 1.60359753 |
| 35 | MP0002405_respiratory_system_inflammati | 1.58025308 |
| 36 | MP0005083_abnormal_biliary_tract | 1.53388258 |
| 37 | MP0008260_abnormal_autophagy | 1.52895162 |
| 38 | MP0002398_abnormal_bone_marrow | 1.49955117 |
| 39 | MP0000716_abnormal_immune_system | 1.44913929 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.44804113 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.42713570 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.42516616 |
| 43 | MP0004130_abnormal_muscle_cell | 1.40209321 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.38522888 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.35790123 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.33631190 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.31226500 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.29901231 |
| 49 | MP0004947_skin_inflammation | 1.29829261 |
| 50 | MP0002722_abnormal_immune_system | 1.21420828 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.17934107 |
| 52 | MP0002429_abnormal_blood_cell | 1.17460978 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.17205645 |
| 54 | MP0001756_abnormal_urination | 1.15580187 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.15475662 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.13977901 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.12676316 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.12166235 |
| 59 | MP0008469_abnormal_protein_level | 1.09337729 |
| 60 | MP0000750_abnormal_muscle_regeneration | 1.08668472 |
| 61 | MP0003828_pulmonary_edema | 1.04739719 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.04322535 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.03869117 |
| 64 | MP0009764_decreased_sensitivity_to | 1.03751204 |
| 65 | MP0001873_stomach_inflammation | 1.02573242 |
| 66 | MP0005076_abnormal_cell_differentiation | 0.99050474 |
| 67 | MP0002928_abnormal_bile_duct | 0.98846226 |
| 68 | MP0000470_abnormal_stomach_morphology | 0.96719558 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.92844368 |
| 70 | MP0001188_hyperpigmentation | 0.89719980 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.89307048 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.89307048 |
| 73 | MP0003866_abnormal_defecation | 0.86469177 |
| 74 | MP0001661_extended_life_span | 0.85428449 |
| 75 | MP0004883_abnormal_blood_vessel | 0.79820051 |
| 76 | MP0005310_abnormal_salivary_gland | 0.78938655 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.77484717 |
| 78 | MP0000858_altered_metastatic_potential | 0.75484071 |
| 79 | MP0002736_abnormal_nociception_after | 0.75411447 |
| 80 | MP0001851_eye_inflammation | 0.73624146 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.72364546 |
| 82 | MP0003448_altered_tumor_morphology | 0.71527026 |
| 83 | MP0003075_altered_response_to | 0.71127938 |
| 84 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70984626 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70311380 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.69526568 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.68671614 |
| 88 | MP0003045_fibrosis | 0.67844853 |
| 89 | MP0002735_abnormal_chemical_nociception | 0.67800496 |
| 90 | MP0001663_abnormal_digestive_system | 0.67315607 |
| 91 | MP0000538_abnormal_urinary_bladder | 0.64793548 |
| 92 | MP0002933_joint_inflammation | 0.64476493 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.62120819 |
| 94 | MP0009931_abnormal_skin_appearance | 0.61001996 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.60973968 |
| 96 | MP0001919_abnormal_reproductive_system | 0.60669907 |
| 97 | MP0000751_myopathy | 0.60624113 |
| 98 | MP0005164_abnormal_response_to | 0.58910198 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.57288250 |
| 100 | MP0008874_decreased_physiological_sensi | 0.57223059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.10689542 |
| 2 | Myositis (HP:0100614) | 4.40759851 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.35177089 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.30258630 |
| 5 | Orchitis (HP:0100796) | 4.27423475 |
| 6 | Optic neuritis (HP:0100653) | 4.02442811 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.02442811 |
| 8 | Rib fusion (HP:0000902) | 3.94868201 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.91074105 |
| 10 | Attenuation of retinal blood vessels (HP:0007843) | 3.77491387 |
| 11 | Stomatitis (HP:0010280) | 3.74087098 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71893160 |
| 13 | Thin bony cortex (HP:0002753) | 3.71198877 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.67820688 |
| 15 | Testicular atrophy (HP:0000029) | 3.59372590 |
| 16 | Facial diplegia (HP:0001349) | 3.49083886 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.45167043 |
| 18 | Poikiloderma (HP:0001029) | 3.43370595 |
| 19 | Hemorrhage of the eye (HP:0011885) | 3.37290235 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.26648653 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.26648653 |
| 22 | Annular pancreas (HP:0001734) | 3.25907835 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22982275 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.22928536 |
| 25 | Hypochromic anemia (HP:0001931) | 3.21593584 |
| 26 | Intestinal fistula (HP:0100819) | 3.21201438 |
| 27 | Joint hemorrhage (HP:0005261) | 3.10128854 |
| 28 | Obstructive lung disease (HP:0006536) | 3.05687676 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05687676 |
| 30 | Recurrent skin infections (HP:0001581) | 3.03454094 |
| 31 | Rectal fistula (HP:0100590) | 3.01154767 |
| 32 | Rectovaginal fistula (HP:0000143) | 3.01154767 |
| 33 | Anorexia (HP:0002039) | 2.97959811 |
| 34 | Episodic fever (HP:0001954) | 2.94853834 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.91929916 |
| 36 | Dyschromatopsia (HP:0007641) | 2.91290222 |
| 37 | Vaginal fistula (HP:0004320) | 2.85888687 |
| 38 | Pustule (HP:0200039) | 2.85469229 |
| 39 | Meningitis (HP:0001287) | 2.84047555 |
| 40 | Increased IgE level (HP:0003212) | 2.81238174 |
| 41 | Cheilitis (HP:0100825) | 2.78230091 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.73438328 |
| 43 | Facial hemangioma (HP:0000329) | 2.72576147 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.68308060 |
| 45 | Ulnar bowing (HP:0003031) | 2.66604714 |
| 46 | Choroideremia (HP:0001139) | 2.66134335 |
| 47 | Basal cell carcinoma (HP:0002671) | 2.62716087 |
| 48 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.62558503 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.59366188 |
| 50 | Encephalitis (HP:0002383) | 2.58908650 |
| 51 | Akinesia (HP:0002304) | 2.56441143 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.48021561 |
| 53 | Widely patent fontanelles and sutures (HP:0004492) | 2.43964066 |
| 54 | Arterial thrombosis (HP:0004420) | 2.43610787 |
| 55 | Gingivitis (HP:0000230) | 2.42406929 |
| 56 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.42024776 |
| 57 | Chest pain (HP:0100749) | 2.40819561 |
| 58 | Abnormality of the costochondral junction (HP:0000919) | 2.40246560 |
| 59 | Decreased central vision (HP:0007663) | 2.38856467 |
| 60 | Vasculitis (HP:0002633) | 2.38329382 |
| 61 | Urticaria (HP:0001025) | 2.31984775 |
| 62 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.31414657 |
| 63 | Popliteal pterygium (HP:0009756) | 2.29386481 |
| 64 | Short chin (HP:0000331) | 2.26363695 |
| 65 | Epistaxis (HP:0000421) | 2.24625204 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.22909506 |
| 67 | Hemoptysis (HP:0002105) | 2.20890164 |
| 68 | Turricephaly (HP:0000262) | 2.20395092 |
| 69 | Petechiae (HP:0000967) | 2.18937166 |
| 70 | Squamous cell carcinoma (HP:0002860) | 2.17186259 |
| 71 | Abnormality of the common coagulation pathway (HP:0010990) | 2.15442714 |
| 72 | Chorioretinal atrophy (HP:0000533) | 2.09387325 |
| 73 | Prolonged partial thromboplastin time (HP:0003645) | 2.08411951 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.07932017 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.06970772 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.06513305 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.06351783 |
| 78 | Cellulitis (HP:0100658) | 2.04433748 |
| 79 | Delayed epiphyseal ossification (HP:0002663) | 2.03731922 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.02834021 |
| 81 | Enlarged epiphyses (HP:0010580) | 2.00833031 |
| 82 | Anteriorly placed anus (HP:0001545) | 1.99842288 |
| 83 | Joint stiffness (HP:0001387) | 1.98418126 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 1.95921928 |
| 85 | Gingival bleeding (HP:0000225) | 1.95229732 |
| 86 | Abnormality of the endocardium (HP:0004306) | 1.94646241 |
| 87 | Flat occiput (HP:0005469) | 1.92389258 |
| 88 | Hypophosphatemic rickets (HP:0004912) | 1.90261274 |
| 89 | Neonatal respiratory distress (HP:0002643) | 1.89853182 |
| 90 | Aplasia of the musculature (HP:0100854) | 1.89608720 |
| 91 | Capillary hemangiomas (HP:0005306) | 1.88627715 |
| 92 | Acute hepatic failure (HP:0006554) | 1.88594267 |
| 93 | Respiratory difficulties (HP:0002880) | 1.88125576 |
| 94 | Abnormality of the fingertips (HP:0001211) | 1.86361932 |
| 95 | Granulocytopenia (HP:0001913) | 1.86010675 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81295423 |
| 97 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81295423 |
| 98 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81295423 |
| 99 | T lymphocytopenia (HP:0005403) | 1.81035107 |
| 100 | Premature graying of hair (HP:0002216) | 1.78961219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.88819858 |
| 2 | MAP4K1 | 3.32490581 |
| 3 | MAP2K3 | 3.15231342 |
| 4 | IRAK4 | 3.14465925 |
| 5 | MAPK15 | 3.10330806 |
| 6 | RIPK4 | 3.08732131 |
| 7 | ERN1 | 2.85851098 |
| 8 | GRK6 | 2.80495857 |
| 9 | EPHB1 | 2.42906353 |
| 10 | TNK2 | 2.30195120 |
| 11 | CSK | 2.29935528 |
| 12 | IRAK2 | 2.25372753 |
| 13 | TYK2 | 2.19155181 |
| 14 | ZAP70 | 2.14387078 |
| 15 | TRIB3 | 1.96124998 |
| 16 | TAOK1 | 1.93540510 |
| 17 | MAP3K2 | 1.82980600 |
| 18 | PRPF4B | 1.66218077 |
| 19 | MAP3K11 | 1.63337363 |
| 20 | BTK | 1.62332832 |
| 21 | MAP3K3 | 1.59690428 |
| 22 | MARK2 | 1.57948180 |
| 23 | FES | 1.57202929 |
| 24 | KSR2 | 1.48620986 |
| 25 | HCK | 1.47455029 |
| 26 | MAP3K1 | 1.42499559 |
| 27 | SIK2 | 1.40081527 |
| 28 | TXK | 1.39298032 |
| 29 | IKBKE | 1.35253558 |
| 30 | JAK2 | 1.34454897 |
| 31 | SIK3 | 1.23600072 |
| 32 | JAK3 | 1.21094558 |
| 33 | IRAK1 | 1.19158166 |
| 34 | LYN | 1.18528386 |
| 35 | TBK1 | 1.17443820 |
| 36 | PRKD2 | 1.16668728 |
| 37 | TESK2 | 1.13328580 |
| 38 | SIK1 | 1.12106678 |
| 39 | SYK | 1.08683646 |
| 40 | PDPK1 | 1.03060868 |
| 41 | YES1 | 0.95328315 |
| 42 | JAK1 | 0.95016877 |
| 43 | PTK6 | 0.93396831 |
| 44 | MAP2K6 | 0.86323554 |
| 45 | DYRK1B | 0.84956560 |
| 46 | SGK3 | 0.83866858 |
| 47 | WNK1 | 0.83651133 |
| 48 | HIPK2 | 0.83299444 |
| 49 | STK11 | 0.82826924 |
| 50 | LCK | 0.81816699 |
| 51 | SMG1 | 0.81158122 |
| 52 | MAP3K14 | 0.78355074 |
| 53 | MUSK | 0.78234051 |
| 54 | MAPK12 | 0.77379474 |
| 55 | MAP2K4 | 0.76762624 |
| 56 | TLK1 | 0.72537245 |
| 57 | PDK1 | 0.72154741 |
| 58 | TAOK3 | 0.70727375 |
| 59 | WNK4 | 0.68357843 |
| 60 | FGR | 0.66711427 |
| 61 | LRRK2 | 0.66619651 |
| 62 | ITK | 0.64910210 |
| 63 | FRK | 0.62742923 |
| 64 | STK38 | 0.62552134 |
| 65 | PRKAA2 | 0.61098039 |
| 66 | FGFR3 | 0.60689568 |
| 67 | RPS6KL1 | 0.60565747 |
| 68 | RPS6KC1 | 0.60565747 |
| 69 | MARK3 | 0.59518744 |
| 70 | MAP3K7 | 0.58037061 |
| 71 | PRKD1 | 0.57468361 |
| 72 | SGK2 | 0.57313064 |
| 73 | IKBKB | 0.57302845 |
| 74 | CDK19 | 0.57235637 |
| 75 | RPS6KA6 | 0.57038402 |
| 76 | RAF1 | 0.54296812 |
| 77 | FGFR4 | 0.53726789 |
| 78 | PKN2 | 0.53724900 |
| 79 | CAMKK1 | 0.53634157 |
| 80 | CDC42BPA | 0.53377814 |
| 81 | PRKCH | 0.52364336 |
| 82 | MAP3K10 | 0.51975641 |
| 83 | TAOK2 | 0.51342356 |
| 84 | OXSR1 | 0.51191350 |
| 85 | EPHA3 | 0.49750695 |
| 86 | CDK12 | 0.48841922 |
| 87 | CDK4 | 0.48731367 |
| 88 | RPS6KA2 | 0.46915104 |
| 89 | RET | 0.46730917 |
| 90 | DAPK2 | 0.46029369 |
| 91 | SGK494 | 0.44469151 |
| 92 | SGK223 | 0.44469151 |
| 93 | CSF1R | 0.44461278 |
| 94 | FYN | 0.42710335 |
| 95 | STK10 | 0.40941522 |
| 96 | NLK | 0.40719707 |
| 97 | PRKCZ | 0.36425571 |
| 98 | PIK3CG | 0.36291280 |
| 99 | MAPK7 | 0.35933409 |
| 100 | MAPK11 | 0.35766943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.51887563 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.67795415 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24015502 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.17028267 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.12153697 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12062139 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.99783185 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91693048 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.88192396 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 1.86641998 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82370528 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81534220 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81196365 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.65933595 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.65375212 |
| 16 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.62136070 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.60686151 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.57911986 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56711217 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.56701445 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.56490003 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54152939 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53891588 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49069101 |
| 25 | Hepatitis C_Homo sapiens_hsa05160 | 1.46273470 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.40135642 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40130702 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.36215796 |
| 29 | Endometrial cancer_Homo sapiens_hsa05213 | 1.35551208 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33771037 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27094940 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26771858 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25732949 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.23557612 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23115341 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.22693353 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.22167517 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20381614 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19616471 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19052588 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.16045985 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15477989 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.15218085 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.14097249 |
| 45 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.10240038 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09392648 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.07561209 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04802554 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03558766 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.00453934 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99752873 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.95596693 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92946761 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92531969 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90055377 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89618055 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.87988468 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87899749 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86114898 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84578570 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83484588 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81981509 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78931120 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76743941 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.75922291 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.75470489 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74812725 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 0.71278500 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70854766 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70844418 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70675643 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70197744 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.69849937 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.68902330 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67641237 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65718094 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64728440 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63207411 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62583981 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62502462 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62425050 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61845789 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61761634 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.61372391 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58936977 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57577623 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57444523 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56787642 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56360073 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54005418 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53945905 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53667566 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51003433 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.50055310 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.49923192 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49187457 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48649016 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47990691 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47694307 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47359764 |

